Helio Genomics, an AI-driven biotechnology company specializing in diagnostics technology and test development for cancer detection, today announced the strategic partnership, in commercializing HelioLiver Dx in Saudi Arabia, with Halub Medical Co., a healthcare company for Saudi Arabia, GCC and Middle East. The test is expected to be commercially available in Saudi Arabia and The Gulf Cooperation Council (GCC) in Q1 2025, with the following 12-month revenue for Helio expected to exceed $10 million dollars.

“We are honored to partner with Halub Medical, a top healthcare provider in the Middle East,” said Shu Li, PhD, Founder and Executive Chairman of the Board of Directors of Helio Genomics. “There are about 25–30% of the worldwide population with non-alcoholic fatty liver disease (NAFLD), which can lead to an increased incidence of liver cancers. We believe HelioLiver Dx can significantly improve the current standard of care, and we are thrilled to contribute to the success of Saudi Arabia’s Health Cluster.”

“We are very pleased to introduce HelioLiver Dx to Saudi Arabia,” said Sheikh Ahmed Almalki, Chairman of Board of Directors of Halub Medical and Founder of Smo Elfaker and Dr. Omar Almalki, CEO Halub Medical. “The breakthrough liver cancer screening test, based on the pivotal trial conducted by 50 of the top medical institutions in the U.S. led by Stanford Medical Centers, demonstrates 4-times better sensitivity. In addition, we believe that a blood-based test such as HelioLiver Dx will have a significantly higher adherence rate, up to 9-times, compared to the current standard of care, ultrasound.”

“With the introduction of the world leading AI-multi-modal platform technology and Helio’s world-renowned scientific team to the Health Cluster of Saudi Arabia, we are looking forward not only to saving lives by much better liver-cancer screening technologies, but also co-developing many other new early detection tests for major degenerative diseases,” said Dr. Talal A Almalki, CEO of Health Cluster, Ministry of Health, Saudi Arabia.